Company Performance Metrics
Dr. Anita Goel, MD, PhD: Chairman & CEO
Nanobiosym® Diagnostics (NBSDx) focuses on the commercialization of the Gene-RADAR®, a portable nanotechnology platform that can rapidly and accurately detect genetic fingerprints from any biological organism, empowering people worldwide with rapid, affordable, and portable diagnostic information about their own health.
To maximize global
humanitarian impact, we have spearheaded the Nanobiosym Global Initiative, which is building innovative public-private partnerships with governments, NGO’s, academic, industrial and global thought leaders to help bring emerging technologies to address some of the world’s most pressing challenges.
I would like to encourage those who resonate with our mission to join our Nanobiosym EcoSystem to explore potential synergies with our organization.
